Inger Kristin Larsen

3.4k total citations · 1 hit paper
64 papers, 2.6k citations indexed

About

Inger Kristin Larsen is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Inger Kristin Larsen has authored 64 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Inger Kristin Larsen's work include Colorectal Cancer Screening and Detection (26 papers), Global Cancer Incidence and Screening (16 papers) and Colorectal Cancer Surgical Treatments (8 papers). Inger Kristin Larsen is often cited by papers focused on Colorectal Cancer Screening and Detection (26 papers), Global Cancer Incidence and Screening (16 papers) and Colorectal Cancer Surgical Treatments (8 papers). Inger Kristin Larsen collaborates with scholars based in Norway, United States and Denmark. Inger Kristin Larsen's co-authors include Freddie Bray, Norbert Perrimon, Lizabeth A. Perkins, Bjørn Møller, Tom Børge Johannesen, Frøydis Langmark, Milada Cvancarova Småstuen, Donald Maxwell Parkin, Trude Eid Robsahm and Geir Hoff and has published in prestigious journals such as Cell, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Inger Kristin Larsen

60 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

2008 678 citations Inger Kristin Larsen, Milada Cvancarova Småstuen et al. European Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inger Kristin Larsen Norway	23	1.3k	695	400	332	312	64	2.6k
Dexter L. Cooper United States	13	1.2k 0.9×	739 1.1×	602 1.5×	284 0.9×	213 0.7×	25	2.8k
Matthew Burnell United Kingdom	25	1.1k 0.9×	637 0.9×	500 1.3×	327 1.0×	591 1.9×	66	3.3k
John F. Deeken United States	24	1.3k 1.1×	948 1.4×	502 1.3×	200 0.6×	158 0.5×	92	3.0k
Catherine C. Lerro United States	8	1.3k 1.0×	758 1.1×	698 1.7×	241 0.7×	242 0.8×	18	2.9k
Anna K.L. Reyners Netherlands	29	1.0k 0.8×	582 0.8×	657 1.6×	313 0.9×	160 0.5×	129	2.5k
Rebecca Kirch United States	10	1.3k 1.1×	797 1.1×	641 1.6×	563 1.7×	217 0.7×	17	3.3k
Susan J. Jordan Australia	34	1.1k 0.9×	750 1.1×	299 0.7×	438 1.3×	218 0.7×	134	3.8k
Mark Hachey United States	10	1.5k 1.2×	797 1.1×	754 1.9×	439 1.3×	251 0.8×	13	3.4k
Johanna M.A. Pijnenborg Netherlands	32	801 0.6×	398 0.6×	262 0.7×	299 0.9×	177 0.6×	160	3.1k
Angela Chetrit Israel	38	772 0.6×	742 1.1×	330 0.8×	581 1.8×	342 1.1×	131	4.3k

Countries citing papers authored by Inger Kristin Larsen

Since Specialization

Citations

This map shows the geographic impact of Inger Kristin Larsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Kristin Larsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Kristin Larsen more than expected).

Fields of papers citing papers by Inger Kristin Larsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Kristin Larsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Kristin Larsen. The network helps show where Inger Kristin Larsen may publish in the future.

Co-authorship network of co-authors of Inger Kristin Larsen

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Kristin Larsen. A scholar is included among the top collaborators of Inger Kristin Larsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Kristin Larsen. Inger Kristin Larsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Myklebust, Tor Åge, Inger Kristin Larsen, Tormod Kyrre Guren, et al.. (2024). Early-onset colorectal cancer incidence in Norway: a national registry-based study (1993-2022) analyzing subsite and morphology trends. SHILAP Revista de lepidopterología. 7. 100065–100065. 2 indexed citations

Nilssen, Yngvar, et al.. (2024). Educational disparities in cancer incidence, stage, and survival in Oslo. SHILAP Revista de lepidopterología. 3(1). 1–1. 1 indexed citations

Dalene, Knut Eirik, Erik R. Sund, Laila Arnesdatter Hopstock, et al.. (2023). Clustering and trajectories of key noncommunicable disease risk factors in Norway: the NCDNOR project. Scientific Reports. 13(1). 14479–14479. 2 indexed citations

Nystad, Wenche, Vidar Hjellvik, Inger Kristin Larsen, et al.. (2023). National health registries – a ‘goldmine’ for studying non-communicable disease occurrence in Norway – the NCDNOR project. Scandinavian Journal of Public Health. 52(8). 988–996. 4 indexed citations

Kørner, Hartwig, Marianne G. Guren, Inger Kristin Larsen, et al.. (2022). Characteristics and fate of patients with rectal cancer not entering a curative-intent treatment pathway: A complete nationwide registry cohort of 3,304 patients. European Journal of Surgical Oncology. 48(8). 1831–1839. 1 indexed citations

Ghiasvand, Reza, Bettina Kulle Andreassen, Jo S Stenehjem, et al.. (2022). Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study. International Journal of Epidemiology. 52(3). 887–898. 2 indexed citations

Andreassen, Bettina Kulle, Jo S Stenehjem, Trond Heir, et al.. (2020). <p>Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study</p>. Clinical Epidemiology. Volume 12. 1389–1401. 11 indexed citations

Breugom, A.J., Esther Bastiaannet, Marianne G. Guren, et al.. (2020). Treatment strategies and overall survival for incurable metastatic colorectal cancer – A EURECCA international comparison including 21,196 patients from the Netherlands and Norway. European Journal of Surgical Oncology. 46(6). 1167–1173. 5 indexed citations

Storeng, Ritsa, et al.. (2020). Validation of Assisted Reproductive Technology in the Medical Birth Registry of Norway Versus the Norwegian Prescription Database. Epidemiology. 31(5). 681–686. 2 indexed citations

10.

Andreassen, Bettina Kulle, Jo S Stenehjem, Inger Kristin Larsen, et al.. (2019). Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case–control study. BMJ Open. 9(2). e025246–e025246. 6 indexed citations

11.

Skyrud, Katrine Damgaard, Tor Åge Myklebust, Freddie Bray, et al.. (2017). How Many Deaths from Colorectal Cancer Can Be Prevented by 2030? A Scenario-Based Quantification of Risk Factor Modification, Screening, and Treatment in Norway. Cancer Epidemiology Biomarkers & Prevention. 26(9). 1420–1426. 10 indexed citations

12.

Storeng, Ritsa, Tor Åge Myklebust, Nan Birgitte Oldereid, et al.. (2017). Cancer Risk in Women Treated with Fertility Drugs According to Parity Status—A Registry-based Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 26(6). 953–962. 46 indexed citations

13.

Robsahm, Trude Eid, Bjarte Aagnes, Anette Hjartåker, et al.. (2013). Body mass index, physical activity, and colorectal cancer by anatomical subsites. European Journal of Cancer Prevention. 22(6). 492–505. 134 indexed citations

14.

Larsen, Inger Kristin & Freddie Bray. (2009). Trends in colorectal cancer incidence in Norway 1962–2006: an interpretation of the temporal patterns by anatomic subsite. International Journal of Cancer. 126(3). 721–732. 76 indexed citations

15.

Larsen, Inger Kristin, Milada Cvancarova Småstuen, Tom Børge Johannesen, et al.. (2008). Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. European Journal of Cancer. 45(7). 1218–1231. 678 indexed citations breakdown →

16.

Larsen, Inger Kristin, Tom Grotmol, Kari Almendingen, & Geir Hoff. (2006). Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterology. 6(1). 5–5. 68 indexed citations

17.

Iversen, Lars, J.S. Kastrup, Søren E. Bjørn, et al.. (1999). Structure and function of the N‐linked glycans of HBP/CAP37/azurocidin: Crystal structure determination and biological characterization of nonglycosylated HBP. Protein Science. 8(10). 2019–2026. 11 indexed citations

18.

Iversen, Lars, Martin Brzozowski, Sven Hastrup, et al.. (1997). Characterization of the allosteric binding pocket of human liver fructose‐1,6‐bisphosphatase by protein crystallography and inhibitor activity studies. Protein Science. 6(5). 971–982. 19 indexed citations

19.

Iversen, Lars, J.S. Kastrup, Inger Kristin Larsen, et al.. (1996). Crystallization and molecular replacement solution of human heparin binding protein. Acta Crystallographica Section D Biological Crystallography. 52(6). 1222–1223. 2 indexed citations

20.

Larsen, Inger Kristin. (1990). Molecular structures of caracemide, an inhibitor of ribonucleotide reductase, and of one of its degradation products. Acta Crystallographica Section C Crystal Structure Communications. 46(4). 600–604. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact